NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GLIS2 | hg19_v2_chr16_+_4382225_4382225 | 0.78 | 6.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_44637526 Show fit | 1.20 |
ENST00000372330.3
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
chr11_+_844067 Show fit | 1.16 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
tetraspanin 4 |
|
chr12_-_53242770 Show fit | 0.93 |
ENST00000304620.4
ENST00000547110.1 |
keratin 78 |
|
chr22_+_23264766 Show fit | 0.73 |
ENST00000390331.2
|
immunoglobulin lambda constant 7 |
|
chr5_-_176836577 Show fit | 0.71 |
ENST00000253496.3
|
coagulation factor XII (Hageman factor) |
|
chr22_-_50699972 Show fit | 0.71 |
ENST00000395778.3
|
mitogen-activated protein kinase 12 |
|
chr2_+_89952792 Show fit | 0.69 |
ENST00000390265.2
|
immunoglobulin kappa variable 1D-33 |
|
chr7_+_150758642 Show fit | 0.69 |
ENST00000488420.1
|
solute carrier family 4 (anion exchanger), member 2 |
|
chr12_-_120907374 Show fit | 0.67 |
ENST00000550458.1
|
serine/arginine-rich splicing factor 9 |
|
chr19_+_45254529 Show fit | 0.67 |
ENST00000444487.1
|
B-cell CLL/lymphoma 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 1.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.0 | 1.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 0.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.0 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.0 | 0.8 | GO:0032094 | response to food(GO:0032094) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.3 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 1.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.9 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.0 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 1.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.0 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |